Literature DB >> 24361863

Masked selection: a straightforward and flexible approach for the selection of binders against specific epitopes and differentially expressed proteins by phage display.

Klervi Even-Desrumeaux1, Damien Nevoltris, Marie Noelle Lavaut, Karima Alim, Jean-Paul Borg, Stéphane Audebert, Brigitte Kerfelec, Daniel Baty, Patrick Chames.   

Abstract

Phage display is a well-established procedure to isolate binders against a wide variety of antigens that can be performed on purified antigens, but also on intact cells. As selection steps are performed in vitro, it is possible to focus the outcome of the selection on relevant epitopes by performing some additional steps, such as depletion or competitive elutions. However in practice, the efficiency of these steps is often limited and can lead to inconsistent results. We have designed a new selection method named masked selection, based on the blockade of unwanted epitopes to favor the targeting of relevant ones. We demonstrate the efficiency and flexibility of this method by selecting single-domain antibodies against a specific portion of a fusion protein, by selecting binders against several members of the seven transmembrane receptor family using transfected HEK cells, or by selecting binders against unknown breast cancer markers not expressed on normal samples. The relevance of this approach for antibody-based therapies was further validated by the identification of four of these markers, Epithelial cell adhesion molecule, Transferrin receptor 1, Metastasis cell adhesion molecule, and Sushi containing domain 2, using immunoprecipitation and mass spectrometry. This new phage display strategy can be applied to any type of antibody fragments or alternative scaffolds, and is especially suited for the rapid discovery and identification of cell surface markers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24361863      PMCID: PMC3916660          DOI: 10.1074/mcp.O112.025486

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  48 in total

1.  Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target.

Authors:  Christian Zahnd; Patrick Amstutz; Andreas Plückthun
Journal:  Nat Methods       Date:  2007-03       Impact factor: 28.547

2.  Breast carcinoma specific antibody selection combining phage display and immunomagnetic cell sorting.

Authors:  Christine Mazuet; Dimitri Lerouge; Marie-Alix Poul; Nathalie Blin
Journal:  Biochem Biophys Res Commun       Date:  2006-07-28       Impact factor: 3.575

3.  Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.

Authors:  D C Yang; F Wang; R L Elliott; J F Head
Journal:  Anticancer Res       Date:  2001 Jan-Feb       Impact factor: 2.480

4.  Identification of colon tumour-associated antigens by phage antibody selections on primary colorectal carcinoma.

Authors:  R C Roovers; E van der Linden; A P de Bruïne; J W Arends; H R Hoogenboom
Journal:  Eur J Cancer       Date:  2001-03       Impact factor: 9.162

5.  Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression.

Authors:  Maya Zigler; Gabriel J Villares; Andrey S Dobroff; Hua Wang; Li Huang; Russell R Braeuer; Takafumi Kamiya; Vladislava O Melnikova; Renduo Song; Ran Friedman; Rhoda M Alani; Menashe Bar-Eli
Journal:  Cancer Res       Date:  2011-04-05       Impact factor: 12.701

6.  Production of a novel camel single-domain antibody specific for the type III mutant EGFR.

Authors:  K Omidfar; M J Rasaee; H Modjtahedi; M Forouzandeh; M Taghikhani; N Golmakani
Journal:  Tumour Biol       Date:  2004 Sep-Dec

Review 7.  Galectin-1: a small protein with major functions.

Authors:  Isabelle Camby; Marie Le Mercier; Florence Lefranc; Robert Kiss
Journal:  Glycobiology       Date:  2006-07-13       Impact factor: 4.313

Review 8.  Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy.

Authors:  Manuel Simon; Nikolas Stefan; Andreas Plückthun; Uwe Zangemeister-Wittke
Journal:  Expert Opin Drug Deliv       Date:  2013-01-14       Impact factor: 6.648

9.  Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.

Authors:  Ghislaine Behar; Patrick Chames; Isabelle Teulon; Amélie Cornillon; Faisal Alshoukr; Françoise Roquet; Martine Pugnière; Jean-Luc Teillaud; Anne Gruaz-Guyon; André Pèlegrin; Daniel Baty
Journal:  FEBS J       Date:  2009-06-15       Impact factor: 5.542

10.  Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.

Authors:  Marcus Schmidt; Dirk Hasenclever; Mitra Schaeffer; Daniel Boehm; Cristina Cotarelo; Eric Steiner; Antje Lebrecht; Wulf Siggelkow; Wolfgang Weikel; Ilka Schiffer-Petry; Susanne Gebhard; Henryk Pilch; Mathias Gehrmann; Hans-Anton Lehr; Heinz Koelbl; Jan G Hengstler; Martin Schuler
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

View more
  13 in total

Review 1.  Nanobodies as Probes for Protein Dynamics in Vitro and in Cells.

Authors:  Oleg Y Dmitriev; Svetlana Lutsenko; Serge Muyldermans
Journal:  J Biol Chem       Date:  2015-12-16       Impact factor: 5.157

Review 2.  Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine.

Authors:  Kegan S Sunderland; Mingying Yang; Chuanbin Mao
Journal:  Angew Chem Int Ed Engl       Date:  2017-01-24       Impact factor: 15.336

3.  A nanobody activating metabotropic glutamate receptor 4 discriminates between homo- and heterodimers.

Authors:  Jordi Haubrich; Joan Font; Robert B Quast; Anne Goupil-Lamy; Pauline Scholler; Damien Nevoltris; Francine Acher; Patrick Chames; Philippe Rondard; Laurent Prézeau; Jean-Philippe Pin
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-17       Impact factor: 11.205

4.  NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies.

Authors:  Sandrine Moutel; Nicolas Bery; Virginie Bernard; Laura Keller; Emilie Lemesre; Ario de Marco; Laetitia Ligat; Jean-Christophe Rain; Gilles Favre; Aurélien Olichon; Franck Perez
Journal:  Elife       Date:  2016-07-19       Impact factor: 8.140

5.  High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli display.

Authors:  Valencio Salema; Carmen Mañas; Lidia Cerdán; Carlos Piñero-Lambea; Elvira Marín; Rob C Roovers; Paul M P Van Bergen En Henegouwen; Luis Ángel Fernández
Journal:  MAbs       Date:  2016-07-29       Impact factor: 5.857

Review 6.  Escherichia coli surface display for the selection of nanobodies.

Authors:  Valencio Salema; Luis Ángel Fernández
Journal:  Microb Biotechnol       Date:  2017-08-03       Impact factor: 5.813

7.  Development of a Phage Display Panning Strategy Utilizing Crude Antigens: Isolation of MERS-CoV Nucleoprotein human antibodies.

Authors:  Chia Chiu Lim; Patrick C Y Woo; Theam Soon Lim
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

8.  Deep Mining of Complex Antibody Phage Pools Generated by Cell Panning Enables Discovery of Rare Antibodies Binding New Targets and Epitopes.

Authors:  Anne Ljungars; Carolin Svensson; Anders Carlsson; Elin Birgersson; Ulla-Carin Tornberg; Björn Frendéus; Mats Ohlin; Mikael Mattsson
Journal:  Front Pharmacol       Date:  2019-07-30       Impact factor: 5.810

Review 9.  Synthetic phage for tissue regeneration.

Authors:  So Young Yoo; Anna Merzlyak; Seung-Wuk Lee
Journal:  Mediators Inflamm       Date:  2014-05-27       Impact factor: 4.711

10.  Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality Control.

Authors:  Michiel M Harmsen; Julian Seago; Eva Perez; Bryan Charleston; Phaedra L Eblé; Aldo Dekker
Journal:  Front Immunol       Date:  2017-08-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.